Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
- Status
- COMPLETED
- Phase
- PHASE3
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
- Status
- COMPLETED
- Phase
- PHASE3
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- NA
Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
HAI Abraxane With Gemcitabine and Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
- Status
- TERMINATED
- Phase
- PHASE3